Nagaraja Suryadevara has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pilot study on the determination of trace elements with hypoglycemic effects in lychee using ICP-MS

    by Huani Chen, Jiaming Hou, Cheng Tan, Nan Chen, Yuan Zhou, Shaojun Huang, Nagaraja Suryadevara, Li Qian

  • Open Access

    BCL Protein and It’s Intrinsic Apoptotic Pathway: A Literature Review

    by Lishaleni Mohan, Mohomed Faizal Umair Ahamed, Charles Arvind Sethuraman Vairavan, Nagaraja Suryadevara

    The BCL (B-cell lymphoma) protein family is a diverse group of regulators critically involved in apoptosis, a tightly controlled process crucial for maintaining tissue homeostasis. Dysregulation of apoptosis is a common feature in cancer, emphasizing the need to comprehend the intricate mechanisms underlying the function of the BCL family. This literature review offers a comprehensive exploration of the structural domain organization of the BCL family, shedding light on how these proteins orchestrate apoptosis. The family comprises anti-apoptotic proteins, pro-apoptotic effectors, and BH3(BCL- 2 homology 3)-only proteins, each with distinct structural features and functional roles in apoptotic signaling pathways. Anti-apoptotic proteins like BCL-2 serve as guardians against cell death by preserving mitochondrial integrity. Pro-apoptotic effectors, on the other hand, actively promote apoptosis by inducing mitochondrial outer membrane permeabilization. BH3-only proteins act as molecular switches, mediating the delicate balance between proand anti-apoptotic signals. This review delves into the specific role of BCL-2, a prominent family member, in various cancers such as lung, breast, and prostate cancers. Highlighting its significance as a potential therapeutic target, the article underscores the importance of understanding the molecular nuances of BCL-2 in cancer progression. Moreover, recent advancements in BCL-2 inhibitor development are discussed, showcasing their potential as targeted therapies for cancer treatment. These inhibitors represent a promising avenue for personalized cancer therapy, aiming to selectively induce apoptosis in cancer cells while sparing normal cells. The review emphasizes the importance of these inhibitors in addressing the specific challenges posed by BCL-2 dysregulation in diverse cancer types. By elucidating the structural and functional aspects of the BCL protein family, this literature review provides valuable insights into apoptotic signaling pathways. It not only deepens our understanding of the molecular intricacies governing cell death but also presents novel strategies to modulate apoptosis in cancer cells. Ultimately, the article highlights the significance of BCL proteins as promising therapeutic targets and the potential of BCL-2 inhibitors for personalized cancer therapy, paving the way for advancements in cancer treatment.


  • What We Know and What We Don't on Antimicrobial Resistance

    by Balasubramani Gangathraprabhu, Santhanam Geethanjali, Kannan Suganya, Balakrishnan Jeyakumar, Nagaraja Suryadevara, Neevashini Chengebroyen, Maruthamuthu Murugan

    On a global scale, the agility of antimicrobial resistance became the foremost health concern in recent years. The evolution and spreading of antimicrobial-resistant bacteria are faster than previously thought. Microbial strain shows resistance to a wide range of antibiotics and is said to be multidrug resistant. Based on the degree of resistance, multidrug resistance is termed extensively as drug-resistant and pandrug-resistant. Antimicrobial-resistant strains are more challenging as very few or no treatment options are available. Antimicrobial resistance is observed in bacterial species and all the disease-causing agents, like fungi, viruses, and parasites. Acquiring a resistance gene, developing membrane impermeability, mutational alteration of the target protein, enzymatic degradation, and efflux pumping system are the key factors for the development of antimicrobial resistance in bacteria. Molecular mechanisms for the appearance of antimicrobial resistance were cited since ancient periods. Many of the present pathways for resistance are highly associated with the past. Many resistance genes are available in the atmosphere, and it will be hard to predict which one would evolve in the host. Recently, a substantial health threat has been noticed with the emergence of multidrug resistance in soil bacteria. This kind of bacteria more evolved to hydrolyze the antibiotics and utilize the antibiotics as a carbon and nitrogen source. Many factors, such as consumption of broad-spectrum antibiotics, environmental pollution particularly by the pharmaceutical industry, and infection control practice in health-care bodies, contribute to multidrug resistance. To date, there are many approaches proposed, and lab trials are carried out to treat multidrug resistant bacteria, such as phage therapy, antimicrobial peptides, antibacterial antibodies, and nanoparticles. Antimicrobial resistance is an ignored health calamity that calls for attention and action.

  • Open Access

    Global Pandemic as a Result of Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak: A Biomedical Perspective

    by Charles Arvind Sethuraman Vairavan, Devarani Rameshnathan, Nagaraja Suryadevara, Gnanendra Shanmugam

  • Efficacy of Moringa oleifera's Therapeutic Compounds and its Antimicrobial Activity

    by Gokila Devi, T. Nagaraja Suryadevara, Divyabharathi, Gopinath, L. R. Venkatasathya Sai Appala Raju Velaga, P. Ponmurugan

    The present work was conducted to study the effective solvents for extracting therapeutic compounds from M. oleifera using GC-MS. In this process the M. oleifera leaf, pod and bark were collected, air dried and powdered and crude extracts were isolated using methanol, ethanol, acetone, petroleum ether, ethyl acetate and water. Phytochemical tests for alkaloids, saponins, protein, flavonoids, carbohydrates, tannins, terpenoids, phenols, glycosides and phytosteroids showed presence in all the components of leaf, pod and bark in one or the other tests. However, the extraction was better in petroleum ether, acetone, ethanol and methanol. The GC-MS analysis of the extracts like Methanol, Ethanol and Acetone showed six common compounds with antimicrobial activity. Antibiotic sensitivity of pathogenic microbes V. cholera, Salmonella sp., E. coli, Klebsiella sp., Pseudomonas sp. against Gentamycin, Streptomycin, Erythromycin, Tetracycline, Kanamycin, Nalidixic acid, Ciproflaxacin, Neomycin and Rifampicin was performed. V. cholera was resistant to Nalidixic acid, Salmonella sp. was not resistant to any of the antibiotics used, E. coli was resistant to Streptomycin, Kanamycin and Ciproflaxacin, Klebsiella was resistant to Nalidixic acid, Pseudomonas was resistant to streptomycin and Rifampicin. Leaf extract with methanol solvent showed highest antibacterial activity greater than the antibiotics used followed by ethanol extract however, acetone extract showed antibacterial activity only for Klebsiella sp. This shows that M. oleifera not only shows antimicrobial activity it also varies with the solvent.


  • Analgesic activity of Annona squamosa Linn fruit peels on Swis Albino mice

    by Venkatasathya Sai Appala Raju Velaga, Nagaraja Suryadevara, Ricca Tai Ching Ying, P Ponmurugan, Gokila Devi


  • Open Access

    Molecular Docking of Multidrug Resistant Klebsiella pneumoniae from River Water of Klang Valley, Malaysia

    by Nagaraja Suryadevara, Yoke Ing Kwan, Gnanendra Shanmugam, Ponmurugan P, Balavinayagamani Ganapathy, Sridevi Subramonie, Venkatasathya Sai Appala Raju Velaga


  • Open Access

    Molecular Characterization of blaTEM and blaCTX-M in ESBLs producing Escherichia coli and Salmonella spp. in Poultry farm and Klebsiella pneumoniae and Proteus spp. in Klang River in Malaysia

    by Nagaraja Suryadevara, Kai Boon Yong, Sharanya Rajan, Yoke Ing Kwan, Michelle Fong Ting Lim

    Introduction: Multidrug resistance bacteria (MDR) has emerged as a public health threat nowadays. High level of resistance to beta-lactam antibiotics among Enterobacteriaceae was conferred by Extended Spectrum Beta-Lactamase (ESBL) in the poultry farm. The waste material of the livestock could pollute the river, leading to the aquatic environment as a reservoir of antimicrobial resistance. Methods: The physiochemical properties of water samples were determined. Gram-negative microorganisms were identified using differential media and biochemical testing. Confirmed bacterial isolates were tested for multidrug resistance by using Kirby Bauer method. The ESBL strains were determined phenotypically using Combination Disc Test (CDT) and Double Disc Synergy Test (DDST). Bacterial genomic DNA was extracted from positive ESBL strains, blaTEM and blaCTX-M genes were amplified using Polymerase Chain Reaction (PCR). The amplified products were sequenced to identify the mutated genes in MDR strains. Results: Out of 88 samples collected from poultry farm, 73 (83.0%) E.coli and 59 (67.0%) Salmonella spp. were identified. Of 50 water samples from Klang River, 31 (62.0%) Klebsiella pneumoniae and 13 (26.0%) Proteus spp. were found. In total, 11 (15.1%) E.coli, 14 (23.7%) Salmonella spp., 12 (38.7%) Klebsiella pneumoniae, and 7 (53.8%) Proteus spp. were MDR strains. From there, 8 (72.7%) E.coli, 7 (50.0%) Salmonella spp., 5 (16.1%) Klebsiella pneumoniae and 5 (38.5%) Proteus spp. were ESBL positive strains. The genes blaTEM and blaCTX-M were seen exhibited in 3 (42.9%) and 7 (87.5%) E.coli , 1(14.3%) and 5(71.4%) Salmonella spp., 1 (20.0%) and 4(80.0%) Klebsiella pneumoniae and 1 (20.0%) and 4 (80.0%) Proteus spp., respectively. Conclusion: Classic blaTEM and blaCTX-M genes were present in E.coli and Salmonella spp. from poultry samples; and Klebsiella pneumoniae and Proteus spp. from river water samples. However, blaCTX-M gene was seen more prominent compared to blaTEM gene in the isolated ESBL strains.

  • Open Access

    Assessment of Cytotoxicity on Moringa Olifera Against Ehrlich Ascites Carcinoma in Swiss Albino Mice

    by Gokila Devi T, Nagaraja Suryadevara S, Gopinath L R

    Objective: The present study determines the potent cytotoxic and antitumor properties of methanolic extract of Moringa oleifera leaves.Material and Method: The leaves were collected from in and around Tiruchengode of Nammakal district of Tamilnadu. The collected leaves were shade dried and powdered and the Methanolic extract was extracted using the soxhlet apparatus. In-vitro cytotoxicity study was done by Tryphan Blue Dye Exclusion method and MTT (3-(4, 5-dimethyl thiazolyl-2)-2, 5- diphenyltetrazolium bromide) assay. In short-term cytotoxicity study by Tryphan Blue Dye Exclusion method the IC50 value against EAC cell lines was found to be 163.91 µg/ml. In Long-term cytotoxicity study by MTT assay the IC50 value against Normal Mouse Embryonic Fibroblast (NIH 3T3) was found to be 260.85 µg/ml for Human Cervical Cancer cells (HeLA) was 182.41 µg/ml for Human Laryngeal Epithelial Carcinoma (HeP-2) was 195.93. µg/ml and for Human Liver Cancer cells (HepG2) was 168.61 µg/ml. The MST of the control group was 17.33 ± 1.53 days, whereas it was 43.67 ± 1.15, 23.67 ± 1.53 and 33.33 ± 1.53 days for the groups treated with MMO (200 and 400mg/kg) and 5 FU respectively (0.001 & 0.001). The increase in lifespan of Tumour-bearing mice treated with MMO and 5-FU was found to be 36. 75, 92.78 and 152.84 respectively.Result: Haematological parameters of a tumour bearing mice on the day 14 were showed significant changes when compared to normal mice. The total WBC count, protein and PCV were found to increase with a reduction in the hemoglobin content of RBC. At the same time interval, MMO (200 and 400mg/kg) treatment could change these parameters near normal. Maximum alternation occurred in the MMO treatment at the dose of (400mg/kg). There was the significant reduction in the Tumour volume of mice treated with MMO (200 and 400 mg/kg/p.o.). The Tumour volume of control animals was 2. 92 ± 0.12 ml where it was 2.55 ± 0.11 ml and 1.82 ± 0.04 ml for the groups treated with MMO (200 and 400mg/kg/p.o) respectively (P < 0.01 & 0.005).Coclusion: The present study provides clear evidence, that the extract of Moringa olifera shows effective cytotoxicity against Ehrlich ascites carcinoma (EAC) cells in Swiss albino mice. A further study about the active principles and mechanism of action of the Methanolic extract of Moringa oleifera at the molecular level was needed.